Showing results (271-280 of 575) with videos related to
Sort By:
Pageof 58
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1990
Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasmJ Jankovic, K Schwartz, D T DonovanEuropean Journal of Pharmacology|November 26, 1985
The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatumM Traub, H R Wagner, M Hassan, et al.Peptides|January 1, 1983
Neurotensin interacts with dopaminergic neurons in rat brainA Reches, R E Burke, D Jiang, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987
The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiencyJ G de Yebenes, S Fahn, V Jackson-Lewis, et al.Pharmacology, Biochemistry, and Behavior|April 1, 1989
Milacemide increases 5-hydroxytryptamine and dopamine levels in rat brain--possible mechanisms of milacemide antimyoclonic property in the p,p'-DDT-induced myoclonusD D Truong, M P Galloway, G Pezzoli, et al.Neurology|August 1, 1990
Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollisP Greene, U Kang, S Fahn, et al.The Journal of Pharmacy and Pharmacology|July 1, 1976
Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnoverS R Snider, C Hutt, B Stein, et al.Pharmacology, Biochemistry, and Behavior|April 1, 1989
The protein synthesis inhibitor, anisomycin, causes exacerbation of the iminodipropionitrile-induced spasmodic dyskinetic syndrome in ratsR Stennett, M Katz, V Jackson-Lewis, et al.Psychopharmacology|January 1, 1985
Attenuation by electroshock treatment of the haloperidol-induced rise in the binding of 3H-imipramine to rat brain membranesA I Barkai, S Kowalik, A Reches, et al.Pageof 58